Patents by Inventor John Montague
John Montague has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11868728Abstract: Techniques for providing and implementing a single skill associated with custom functionality and system-provided functionality are described. The skill may be used to invoke functionality in response to a user input without requiring a user remember exact formulations to cause the functionality to be performed. The skill may be associated with more than one domain. For example, the skill may be associated with custom sample user inputs (corresponding to the custom functionality) that correspond to a custom domain while the skill may also be associated with system-provided sample user inputs (corresponding to the system-provided functionality) associated with a non-custom domain.Type: GrantFiled: December 12, 2018Date of Patent: January 9, 2024Assignee: Amazon Technologies, Inc.Inventors: Jeffery Alan Meissner, Ernesto Gonzalez, Nikhil Mehta, Anemona Oana Hagea, John Montague Howard
-
Publication number: 20230419957Abstract: Described are techniques for linking generating a skill-stored user profile, and linking same with a natural language processing (NLP) system-stored user profile. In at least some examples, a user may provide a natural language input to a NLP system. The NLP system may determine a skill is to process to perform an action responsive to the natural language input. To perform the action, the skill may require the user have a user profile stored by the skill, but the user may not have such a user profile. However, the NLP system may store a user profile for the user. The NLP system may determine the user profile stored thereby and may send, with user permission, information in the user profile to the skill. The skill may use the received information to generate and store a user profile for the user. Thereafter, the skill may provide the NLP system with a user profile identifier that the skill may use to identify the user's profile stored thereby.Type: ApplicationFiled: September 14, 2023Publication date: December 28, 2023Inventors: Fabien Hertschuh, Mohit Mittal, John Montague Howard, Akshit Proothi, Rahul Manne
-
Patent number: 11810555Abstract: Described are techniques for linking generating a skill-stored user profile, and linking same with a natural language processing (NLP) system-stored user profile. In at least some examples, a user may provide a natural language input to a NLP system. The NLP system may determine a skill is to process to perform an action responsive to the natural language input. To perform the action, the skill may require the user have a user profile stored by the skill, but the user may not have such a user profile. However, the NLP system may store a user profile for the user. The NLP system may determine the user profile stored thereby and may send, with user permission, information in the user profile to the skill. The skill may use the received information to generate and store a user profile for the user. Thereafter, the skill may provide the NLP system with a user profile identifier that the skill may use to identify the user's profile stored thereby.Type: GrantFiled: August 18, 2021Date of Patent: November 7, 2023Assignee: Amazon Technologies, Inc.Inventors: Fabien Hertschuh, Mohit Mittal, John Montague Howard, Akshit Proothi, Rahul Manne
-
Publication number: 20220036892Abstract: Described are techniques for linking generating a skill-stored user profile, and linking same with a natural language processing (NLP) system-stored user profile. In at least some examples, a user may provide a natural language input to a NLP system. The NLP system may determine a skill is to process to perform an action responsive to the natural language input. To perform the action, the skill may require the user have a user profile stored by the skill, but the user may not have such a user profile. However, the NLP system may store a user profile for the user. The NLP system may determine the user profile stored thereby and may send, with user permission, information in the user profile to the skill. The skill may use the received information to generate and store a user profile for the user. Thereafter, the skill may provide the NLP system with a user profile identifier that the skill may use to identify the user's profile stored thereby.Type: ApplicationFiled: August 18, 2021Publication date: February 3, 2022Inventors: Fabien Hertschuh, Mohit Mittal, John Montague Howard, Akshit Proothi, Rahul Manne
-
Patent number: 11114090Abstract: Described are techniques for linking generating a skill-stored user profile, and linking same with a natural language processing (NLP) system-stored user profile. In at least some examples, a user may provide a natural language input to a NLP system. The NLP system may determine a skill is to process to perform an action responsive to the natural language input. To perform the action, the skill may require the user have a user profile stored by the skill, but the user may not have such a user profile. However, the NLP system may store a user profile for the user. The NLP system may determine the user profile stored thereby and may send, with user permission, information in the user profile to the skill. The skill may use the received information to generate and store a user profile for the user. Thereafter, the skill may provide the NLP system with a user profile identifier that the skill may use to identify the user's profile stored thereby.Type: GrantFiled: June 27, 2019Date of Patent: September 7, 2021Assignee: AMAZON TECHNOLOGIES, INC.Inventors: Fabien Hertschuh, Mohit Mittal, John Montague Howard, Akshit Proothi, Rahul Manne
-
Patent number: 9114343Abstract: A filtration unit and a method of installing a filtration unit are provided. The rectangular filtration unit includes a filter element for filtering fluid. The frame includes a first portion and a second portion. The frame supports the filter element and the frame defines an opening. A first dimension of the filtration unit measured between the exterior of the first portion and the opening is greater than a second dimension of the filtration unit measured between the exterior of the second portion and the opening. In a further example, the filtration unit is mounted in a top section and a bottom section of a holding frame.Type: GrantFiled: September 23, 2011Date of Patent: August 25, 2015Assignee: BHA Altair, LLCInventors: Abhijeet Madhukar Kulkarni, Richard Michael Ashley Mann, Philip John Montague, Kevin Anthony Saunders, Stephen David Hiner, Marcus Carr Walters
-
Publication number: 20130074463Abstract: A filtration unit and a method of installing a filtration unit are provided. The rectangular filtration unit includes a filter element for filtering fluid. The frame includes a first portion and a second portion. The frame supports the filter element and the frame defines an opening. A first dimension of the filtration unit measured between the exterior of the first portion and the opening is greater than a second dimension of the filtration unit measured between the exterior of the second portion and the opening. In a further example, the filtration unit is mounted in a top section and a bottom section of a holding frame.Type: ApplicationFiled: September 23, 2011Publication date: March 28, 2013Applicant: General Electric CompanyInventors: Abhijeet Madhukar Kulkarni, Richard Michael Ashley Mann, Philip John Montague, Kevin Anthony Saunders, Stephen David Hiner, Marcus Carr Walters
-
Publication number: 20120189556Abstract: A pharmaceutical composition comprising an anticholinergic and a steroid, optionally together with a pharmaceutically acceptable excipient, the anticholinergic and the steroid optionally in the form of their enantiomers, mixtures of their enantiomers, their racemates, their solvates, or their hydrates, processes for preparing them, and their use in the treatment of respiratory tract diseases.Type: ApplicationFiled: March 29, 2012Publication date: July 26, 2012Applicant: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KGInventors: Michel PAIRET, Michael P. PIEPER, Christopher John Montague MEADE, Richard REICHL, Christel SCHMELZER
-
Publication number: 20110268668Abstract: A process for nebulizing highly concentrated solutions of insulin for administration by inhalation.Type: ApplicationFiled: July 14, 2011Publication date: November 3, 2011Inventors: Herbert Lamche, Christopher John Montague Meade, Bernd Zierenberg, Ralph Christian Reimholz
-
Publication number: 20110038806Abstract: A pharmaceutical composition comprising a compound of formula 1 wherein X? is an anion with a single negative charge, and a betamimetic, optionally together with a pharmaceutically acceptable excipient, the compound of formula 1 and the betamimetic optionally in the form of their enantiomers, mixtures of their enantiomers, their racemates, their solvates, or their hydrates, processes for preparing them, and their use in the treatment of respiratory tract diseases.Type: ApplicationFiled: October 26, 2010Publication date: February 17, 2011Applicant: Boehringer Ingelheim International GmbHInventors: Christopher John Montague MEADE, Michel PAIRET, Michael P. PIEPER
-
Patent number: 7867987Abstract: A pharmaceutical composition comprising a compound of formula 1 wherein X? is an anion with a single negative charge, and a betamimetic, optionally together with a pharmaceutically acceptable excipient, the compound of formula 1 and the betamimetic optionally in the form of their enantiomers, mixtures of their enantiomers, their racemates, their solvates, or their hydrates, processes for preparing them, and their use in the treatment of respiratory tract diseases.Type: GrantFiled: July 15, 2004Date of Patent: January 11, 2011Assignee: Boehringer Ingelheim International GmbHInventors: Christopher John Montague Meade, Michel Pairet, Michael P. Pieper
-
Publication number: 20100330186Abstract: A pharmaceutical composition comprising a compound of formula 1 wherein X? is an anion with a single negative charge, and a betamimetic, optionally together with a pharmaceutically acceptable excipient, the compound of formula 1 and the betamimetic optionally in the form of their enantiomers, mixtures of their enantiomers, their racemates, their solvates, or their hydrates, processes for preparing them, and their use in the treatment of respiratory tract diseases.Type: ApplicationFiled: September 3, 2010Publication date: December 30, 2010Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBHInventors: Christopher John Montague MEADE, Michel PAIRET, Michael P. PIEPER
-
Patent number: 7851483Abstract: A pharmaceutical composition comprising: (a) a salt of formula 1 wherein: X? is an anion with a single negative charge; and (b) a steroid 2, processes for preparing such pharmaceutical composition, and their use in the treatment of respiratory complaints.Type: GrantFiled: April 20, 2006Date of Patent: December 14, 2010Assignee: Boehringer Ingelheim Pharma GmbH & Co. KGInventors: Rolf Banholzer, Helmut Meissner, Gerd Morschhaeuser, Michael P. Pieper, Gerald Pohl, Richard Reichl, Georg Speck, Christopher John Montague Meade, Michel Pairet
-
Publication number: 20100310477Abstract: A pharmaceutical composition comprising an anticholinergic and at least one additional active ingredient selected from among corticosteroids, dopamine agonistes, PDE-IV inhibitors, NK1-antagonists, endothelin antagonists, antihistamines, and EGFR-kinase inhibitors, processes for preparing them and their use in the treatment of respiratory diseases.Type: ApplicationFiled: August 13, 2010Publication date: December 9, 2010Applicant: Boehringer Ingelheim Pharma GmbH & Co. Kg.Inventors: Michel Pairet, Michael P. Pieper, Christopher John Montague Meade, Richard Reichl, Christel Schmelzer, Birgit Jung
-
Patent number: 7776315Abstract: A pharmaceutical composition comprising an anticholinergic and at least one additional active ingredient selected from among corticosteroids, dopamine agonistes, PDE-IV inhibitors, NK1-antagonists, endothelin antagonists, antihistamines, and EGFR-kinase inhibitors, processes for preparing them and their use in the treatment of respiratory diseases.Type: GrantFiled: December 8, 2004Date of Patent: August 17, 2010Assignee: Boehringer Ingelheim Pharma GmbH & Co. KGInventors: Michel Pairet, Michael P. Pieper, Christopher John Montague Meade, Richard Reichl, Christel Schmelzer, Birgit Jung
-
Publication number: 20090155185Abstract: A pharmaceutical composition comprising an anticholinergic and a betamimetic of formula 2 optionally together with a pharmaceutically acceptable excipient, the anticholinergic and the betamimetic optionally in the form of their enantiomers, mixtures of their enantiomers, their racemates, their solvates, or their hydrates, processes for preparing them, and their use in the treatment of asthma, COPD, or other inflammatory or obstructive respiratory complaints.Type: ApplicationFiled: January 7, 2009Publication date: June 18, 2009Inventors: Christopher John Montague Meade, Michel Pairet, Michael P. Pieper, Ingo Konetzki
-
Patent number: 7507745Abstract: The present invention relates to novel pharmaceutical compositions based on fluorene carboxylic acid ester derived anticholinergics of formula 1 and soluble TNF receptor fusion proteins, processes for preparing them and their use in the treatment of respiratory diseases.Type: GrantFiled: January 18, 2005Date of Patent: March 24, 2009Assignee: Boehringer Ingelheim International GmbHInventors: Christopher John Montague Meade, Michel Pairet, Michael P. Pieper
-
Patent number: 7417051Abstract: A pharmaceutical composition comprising: (a) a salt of formula 1 wherein: X? is an anion with a single negative charge; and (b) a betamimetic 2, or a solvate or hydrate thereof, optionally in the form of the enantiomers, mixtures of the enantiomers, or in the form of the racemates thereof, processes for preparing them and their use in the treatment of respiratory complaints.Type: GrantFiled: March 24, 2003Date of Patent: August 26, 2008Assignee: Boehringer Ingelheim Pharma GmbH & Co. KGInventors: Rolf Banholzer, Helmut Meissner, Gerd Morschhaeuser, Michael P. Pieper, Gerald Pohl, Richard Reichl, Georg Speck, Christopher John Montague Meade, Michel Pairet, Ingo Konetzki
-
Patent number: 7244742Abstract: A pharmaceutical composition comprising: (a) an anticholinergic of formula 1 wherein X? is an anion with a single negative charge; (b) a corticosteroid; and (c) a betamimetic, wherein each component (a), (b), and (c) are optionally in the form of the solvates or hydrates thereof, processes for preparing them, and their use in the treatment of respiratory diseases.Type: GrantFiled: July 23, 2003Date of Patent: July 17, 2007Assignee: Boehringer Ingelheim Pharma GmbH & Co KGInventors: Michael Paul Pieper, Christopher John Montague Meade, Michel Pairet
-
Publication number: 20060199433Abstract: An improved rotating latch connector system is disclosed wherein a connector assembly of the connector system includes on or more improvements such as connector lugs having a narrow width chamfered edges, or an asymmetric apex. Improvements to the receptacle assembly may include a modified two-stage entry cone, placement of one or more anti-rotation barriers within the receptacle assembly and modifications to the receptacle lugs similar to those described for the connector lugs.Type: ApplicationFiled: September 21, 2005Publication date: September 7, 2006Inventors: David Riggs, Edward Arlt, John Montague